155 related articles for article (PubMed ID: 37942464)
1. Epidemiology and Risk Factors for Invasive Fungal Infections in Pancreas Transplant in the Absence of Postoperative Antifungal Prophylaxis.
Zachary J; Chen JM; Sharfuddin A; Yaqub M; Lutz A; Powelson J; Fridell JA; Barros N
Open Forum Infect Dis; 2023 Nov; 10(11):ofad478. PubMed ID: 37942464
[TBL] [Abstract][Full Text] [Related]
2. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.
Linder KA; Kauffman CA; Patel TS; Fitzgerald LJ; Richards BJ; Miceli MH
Transpl Infect Dis; 2021 Feb; 23(1):e13448. PubMed ID: 33448560
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.
Chong PP; Kennedy CC; Hathcock MA; Kremers WK; Razonable RR
Clin Transplant; 2015 Apr; 29(4):311-8. PubMed ID: 25604399
[TBL] [Abstract][Full Text] [Related]
6. Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.
Baker AW; Maziarz EK; Arnold CJ; Johnson MD; Workman AD; Reynolds JM; Perfect JR; Alexander BD
Clin Infect Dis; 2020 Jan; 70(1):30-39. PubMed ID: 30801642
[TBL] [Abstract][Full Text] [Related]
7. A simplified regimen of targeted antifungal prophylaxis in liver transplant recipients: A single-center experience.
Lavezzo B; Patrono D; Tandoi F; Martini S; Fop F; Ballerini V; Stratta C; Skurzak S; Lupo F; Strignano P; Donadio PP; Salizzoni M; Romagnoli R; De Rosa FG
Transpl Infect Dis; 2018 Apr; 20(2):e12859. PubMed ID: 29427394
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Invasive Fungal Infections in Liver Transplant Recipients under Targeted Echinocandin Prophylaxis.
Breitkopf R; Treml B; Simmet K; Bukumirić Z; Fodor M; Senoner T; Rajsic S
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836055
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ
Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822
[TBL] [Abstract][Full Text] [Related]
10. Fungal infections in lung transplantation.
Samanta P; Clancy CJ; Nguyen MH
J Thorac Dis; 2021 Nov; 13(11):6695-6707. PubMed ID: 34992845
[TBL] [Abstract][Full Text] [Related]
11. Targeted versus universal antifungal prophylaxis among liver transplant recipients.
Eschenauer GA; Kwak EJ; Humar A; Potoski BA; Clarke LG; Shields RK; Abdel-Massih R; Silveira FP; Vergidis P; Clancy CJ; Nguyen MH
Am J Transplant; 2015 Jan; 15(1):180-9. PubMed ID: 25359455
[TBL] [Abstract][Full Text] [Related]
12. Invasive fungal infection after heart transplantation: A 7-year, single-center experience.
Echenique IA; Angarone MP; Gordon RA; Rich J; Anderson AS; McGee EC; Abicht TO; Kang J; Stosor V
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943503
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.
Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010
[TBL] [Abstract][Full Text] [Related]
14. Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
Tissot F; Pascual M; Hullin R; Yerly P; Tozzi P; Meylan P; Manuel O
Transplantation; 2014 Jun; 97(11):1192-7. PubMed ID: 24521774
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study.
Pappas PG; Andes D; Schuster M; Hadley S; Rabkin J; Merion RM; Kauffman CA; Huckabee C; Cloud GA; Dismukes WE; Karchmer AW
Am J Transplant; 2006 Feb; 6(2):386-91. PubMed ID: 16426325
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and outcome of systemic fungal infections in renal transplant recipients - A tertiary care experience.
Shekar M; Elumalai R; Elayaperumal I; Yelahanka RP; Anandkumar DG; Bandi VK; Matcha J
Saudi J Kidney Dis Transpl; 2019; 30(5):1137-1143. PubMed ID: 31696853
[TBL] [Abstract][Full Text] [Related]
19. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
20. The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center's Experience.
Atoui A; Omeirat N; Fakhreddine O; El Alam R; Kanafani Z; Abou Dalle I; Bazarbachi A; El-Cheikh J; Kanj SS
J Fungi (Basel); 2021 Oct; 7(11):. PubMed ID: 34829213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
